1. Neuropilin-1, a myeloid cell-specific protein, is an inhibitor of HIV-1 infectivity
- Author
-
Shumei Wang, Li Zhao, Xiaowei Zhang, Jingjing Zhang, Hong Shang, and Guoxin Liang
- Subjects
CD4-Positive T-Lymphocytes ,Multidisciplinary ,dendritic cell ,Macrophages ,Virion ,HIV Infections ,Dendritic Cells ,macrophage ,Biological Sciences ,Virus Replication ,Microbiology ,Neuropilin-1 ,Cell Line ,myeloid cells ,HIV-1 ,Humans ,NRP-1 - Abstract
Significance Macrophages and dendritic cells represent an important target for HIV-1 replication in vivo as they serve both as a vehicle for virus dissemination throughout the body and a viral reservoir. However, myeloid cells can support persistent replication of HIV-1 and, in contrast to infected T cells, demonstrate lower productivity. Using proteomics, we discovered that NRP-1 is a host restriction factor that inhibits HIV-1 from infecting macrophages and dendritic cells. NRP-1 is incorporated into the HIV-1 virion particle to inhibit its ability to attach to target cells in a viral envelope glycoprotein-independent manner. Overall, these results provide insights into the ability of myeloid lineage cells to utilize NRP-1 to interfere with HIV-1 infection., Myeloid lineage cells such as macrophages and dendritic cells (DCs), targeted by HIV-1, are important vehicles for virus dissemination through the body as well as viral reservoirs. Compared to activated lymphocytes, myeloid cells are collectively more resistant to HIV-1 infection. Here we report that NRP-1, encoding transmembrane protein neuropilin-1, is highly expressed in macrophages and DCs but not CD4+ T cells, serving as an anti-HIV factor to inhibit the infectivity of HIV-1 progeny virions. Silencing NRP-1 enhanced the transmission of HIV-1 in macrophages and DCs significantly and increased the infectivity of the virions produced by these cells. We further demonstrated that NRP-1 was packaged into the progeny virions to inhibit their ability to attach to target cells, thus reducing the infectivity of the virions. These data indicate that NRP-1 is a newly identified antiviral protein highly produced in both macrophages and DCs that inhibit HIV-1 infectivity; thus, NRP-1 may be a novel therapeutic strategy for the treatment of HIV-1 infection.
- Published
- 2021